Skip to main content
Top
Published in: Neurology and Therapy 4/2022

Open Access 26-08-2022 | SARS-CoV-2 | Original Research

Post-COVID-19 Syndrome is Rarely Associated with Damage of the Nervous System: Findings from a Prospective Observational Cohort Study in 171 Patients

Authors: Michael Fleischer, Fabian Szepanowski, Muriel Tovar, Klaas Herchert, Hannah Dinse, Adam Schweda, Anne K. Mausberg, Dagny Holle-Lee, Martin Köhrmann, Julia Stögbauer, Daniel Jokisch, Martha Jokisch, Cornelius Deuschl, Eva-Maria Skoda, Martin Teufel, Mark Stettner, Christoph Kleinschnitz

Published in: Neurology and Therapy | Issue 4/2022

Login to get access

Abstract

Introduction

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can affect multiple organs. Reports of persistent or newly emergent symptoms, including those related to the nervous system, have increased over the course of the pandemic, leading to the introduction of post-COVID-19 syndrome. However, this novel syndrome is still ill-defined and structured objectification of complaints is scarce. Therefore, we performed a prospective observational cohort study to better define and validate subjective neurological disturbances in patients with post-COVID-19 syndrome.

Methods

A total of 171 patients fulfilling the post-COVID-19 WHO Delphi consensus criteria underwent a comprehensive neurological diagnostic work-up including neurovascular, electrophysiological, and blood analysis. In addition, magnetic resonance imaging (MRI) and lumbar puncture were conducted in subgroups of patients. Furthermore, patients underwent neuropsychological, psychosomatic, and fatigue assessment.

Results

Patients were predominantly female, middle-aged, and had incurred mostly mild-to-moderate acute COVID-19. The most frequent post-COVID-19 complaints included fatigue, difficulties in concentration, and memory deficits. In most patients (85.8%), in-depth neurological assessment yielded no pathological findings. In 97.7% of the cases, either no diagnosis other than post COVID-19 syndrome, or no diagnosis likely related to preceding acute COVID-19 could be established. Sensory or motor complaints were more often associated with a neurological diagnosis other than post-COVID-19 syndrome. Previous psychiatric conditions were identified as a risk factor for developing post-COVID-19 syndrome. We found high somatization scores in our patient group that correlated with cognitive deficits and the extent of fatigue.

Conclusions

Albeit frequently reported by patients, objectifiable affection of the nervous system is rare in post-COVID-19 syndrome. Instead, elevated levels of somatization point towards a pathogenesis potentially involving psychosomatic factors. However, thorough neurological assessment is important in this patient group in order to not miss neurological diseases other than post-COVID-19.
Literature
2.
go back to reference Michelen M, Manoharan L, Elkheir N, Cheng V, Dagens A, Hastie C, et al. Characterising long COVID: a living systematic review. BMJ Glob Health. 2021;6(9): e005427.CrossRef Michelen M, Manoharan L, Elkheir N, Cheng V, Dagens A, Hastie C, et al. Characterising long COVID: a living systematic review. BMJ Glob Health. 2021;6(9): e005427.CrossRef
3.
go back to reference World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus. World Health Organization; 2021. World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus. World Health Organization; 2021.
4.
go back to reference Pavli A, Theodoridou M, Maltezou HC. Post-COVID syndrome: incidence, clinical spectrum, and challenges for primary healthcare professionals. Arch Med Res. 2021;52(6):575–81.CrossRef Pavli A, Theodoridou M, Maltezou HC. Post-COVID syndrome: incidence, clinical spectrum, and challenges for primary healthcare professionals. Arch Med Res. 2021;52(6):575–81.CrossRef
5.
go back to reference Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1):16144.CrossRef Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1):16144.CrossRef
6.
go back to reference Ayoubkhani D, Bosworthor M. Self-reported long COVID after infection with Omicron variant in the UK. Office of National Statistics: Office for National Statistics; 2022. Ayoubkhani D, Bosworthor M. Self-reported long COVID after infection with Omicron variant in the UK. Office of National Statistics: Office for National Statistics; 2022.
7.
go back to reference Chen Y, Xu Z, Wang P, Li X, Shuai Z, Ye D, et al. New-onset autoimmune phenomena post-COVID-19 vaccination. Immunology. 2022;165(4):386–401.CrossRef Chen Y, Xu Z, Wang P, Li X, Shuai Z, Ye D, et al. New-onset autoimmune phenomena post-COVID-19 vaccination. Immunology. 2022;165(4):386–401.CrossRef
8.
go back to reference Thallapureddy K, Thallapureddy K, Zerda E, Suresh N, Kamat D, Rajasekaran K, et al. Long-term complications of COVID-19 infection in adolescents and children. Curr Pediatr Rep. 2022;10(1):11–7.CrossRef Thallapureddy K, Thallapureddy K, Zerda E, Suresh N, Kamat D, Rajasekaran K, et al. Long-term complications of COVID-19 infection in adolescents and children. Curr Pediatr Rep. 2022;10(1):11–7.CrossRef
9.
go back to reference Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re’em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClin Med. 2021;38: 101019. Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re’em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClin Med. 2021;38: 101019.
10.
go back to reference Fernández-de-las-Peñas C, Palacios-Ceña D, Gómez-Mayordomo V, Florencio LL, Cuadrado ML, Plaza-Manzano G, et al. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: a systematic review and meta-analysis. Eur J Intern Med. 2021;92:55–70.CrossRef Fernández-de-las-Peñas C, Palacios-Ceña D, Gómez-Mayordomo V, Florencio LL, Cuadrado ML, Plaza-Manzano G, et al. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: a systematic review and meta-analysis. Eur J Intern Med. 2021;92:55–70.CrossRef
11.
go back to reference Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol. 2022;23(2):194–202.CrossRef Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol. 2022;23(2):194–202.CrossRef
12.
go back to reference Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604(7907):697–707.CrossRef Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604(7907):697–707.CrossRef
13.
go back to reference John S, Hussain SI, Piechowski-Jozwiak B, Dibu J, Kesav P, Bayrlee A, et al. Clinical characteristics and admission patterns of stroke patients during the COVID 19 pandemic: a single center retrospective, observational study from the Abu Dhabi. United Arab Emirates Clin Neurol Neurosurg. 2020;199: 106227.CrossRef John S, Hussain SI, Piechowski-Jozwiak B, Dibu J, Kesav P, Bayrlee A, et al. Clinical characteristics and admission patterns of stroke patients during the COVID 19 pandemic: a single center retrospective, observational study from the Abu Dhabi. United Arab Emirates Clin Neurol Neurosurg. 2020;199: 106227.CrossRef
14.
go back to reference Grist JT, Collier GJ, Walters H, Kim M, Chen M, Abu Eid G, et al. Lung abnormalities depicted with hyperpolarized xenon MRI in patients with long COVID. Radiology. 2022;24: 220069. Grist JT, Collier GJ, Walters H, Kim M, Chen M, Abu Eid G, et al. Lung abnormalities depicted with hyperpolarized xenon MRI in patients with long COVID. Radiology. 2022;24: 220069.
15.
go back to reference Wallukat G, Hohberger B, Wenzel K, Fürst J, Schulze-Rothe S, Wallukat A, et al. Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J Transl Autoimmun. 2021;4: 100100.CrossRef Wallukat G, Hohberger B, Wenzel K, Fürst J, Schulze-Rothe S, Wallukat A, et al. Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J Transl Autoimmun. 2021;4: 100100.CrossRef
16.
go back to reference Bisenius S, Kersting A. Psychosomatische Aspekte von long-Covid. MMW Fortschritte Med. 2022;164(1):40–1.CrossRef Bisenius S, Kersting A. Psychosomatische Aspekte von long-Covid. MMW Fortschritte Med. 2022;164(1):40–1.CrossRef
17.
go back to reference Stengel A, Malek N, Zipfel S, Goepel S. Long haulers—What is the evidence for post-COVID fatigue? Front Psychiatry. 2021;21(12): 677934.CrossRef Stengel A, Malek N, Zipfel S, Goepel S. Long haulers—What is the evidence for post-COVID fatigue? Front Psychiatry. 2021;21(12): 677934.CrossRef
18.
go back to reference Forte G, Favieri F, Tambelli R, Casagrande M. COVID-19 Pandemic in the Italian population: validation of a post-traumatic stress disorder questionnaire and prevalence of PTSD symptomatology. Int J Environ Res Public Health. 2020;17(11):4151.CrossRef Forte G, Favieri F, Tambelli R, Casagrande M. COVID-19 Pandemic in the Italian population: validation of a post-traumatic stress disorder questionnaire and prevalence of PTSD symptomatology. Int J Environ Res Public Health. 2020;17(11):4151.CrossRef
19.
go back to reference Wong TL, Weitzer DJ. Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)—a systemic review and comparison of clinical presentation and symptomatology. Medicina (Mex). 2021;57(5):418.CrossRef Wong TL, Weitzer DJ. Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)—a systemic review and comparison of clinical presentation and symptomatology. Medicina (Mex). 2021;57(5):418.CrossRef
20.
go back to reference Rossi Ferrario S, Panzeri A, Cerutti P, Sacco D. The psychological experience and intervention in post-acute COVID-19 inpatients. Neuropsychiatr Dis Treat. 2021;17:413–22.CrossRef Rossi Ferrario S, Panzeri A, Cerutti P, Sacco D. The psychological experience and intervention in post-acute COVID-19 inpatients. Neuropsychiatr Dis Treat. 2021;17:413–22.CrossRef
21.
go back to reference von Oertzen TJ, Macerollo A, Leone MA, Beghi E, Crean M, Oztuk S, et al. EAN consensus statement for management of patients with neurological diseases during the COVID-19 pandemic. Eur J Neurol. 2021;28(1):7–14.CrossRef von Oertzen TJ, Macerollo A, Leone MA, Beghi E, Crean M, Oztuk S, et al. EAN consensus statement for management of patients with neurological diseases during the COVID-19 pandemic. Eur J Neurol. 2021;28(1):7–14.CrossRef
22.
go back to reference Welsh KA, Butters N, Mohs RC, Beekly D, Edland S, Fillenbaum G, et al. The consortium to establish a registry for Alzheimer’s disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology. 1994;44(4):609–609.CrossRef Welsh KA, Butters N, Mohs RC, Beekly D, Edland S, Fillenbaum G, et al. The consortium to establish a registry for Alzheimer’s disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology. 1994;44(4):609–609.CrossRef
23.
go back to reference Brähler E, Holling H, Leutner D, Petermann F, editors. Brickenkamp-Handbuch psychologischer und pädagogischer Tests. 1. 3., vollst. überarb. u. erw. Aufl. Göttingen Bern: Hogrefe Verl. für Psychologie; 2002. 726 p. Brähler E, Holling H, Leutner D, Petermann F, editors. Brickenkamp-Handbuch psychologischer und pädagogischer Tests. 1. 3., vollst. überarb. u. erw. Aufl. Göttingen Bern: Hogrefe Verl. für Psychologie; 2002. 726 p.
24.
go back to reference Aschenbrenner O, Lange K. Regensburger Wortflüssigkeits-Test. Goettingen, Bern: Hogrefe Verl. für Psychologie; 2002. Aschenbrenner O, Lange K. Regensburger Wortflüssigkeits-Test. Goettingen, Bern: Hogrefe Verl. für Psychologie; 2002.
25.
go back to reference Tombaugh T. Trail Making Test A and B: normative data stratified by age and education. Arch Clin Neuropsychol. 2004;19(2):203–14.CrossRef Tombaugh T. Trail Making Test A and B: normative data stratified by age and education. Arch Clin Neuropsychol. 2004;19(2):203–14.CrossRef
26.
go back to reference Härting C, Neufeld H, Calabrese P. Wechsler Gedächtnistest- Revidierte Fassung. Bern: Hans Huber; 2000. Härting C, Neufeld H, Calabrese P. Wechsler Gedächtnistest- Revidierte Fassung. Bern: Hans Huber; 2000.
27.
go back to reference Smith A. Symbol digits modalities test: manual. Western Psychological Services; 2007. Smith A. Symbol digits modalities test: manual. Western Psychological Services; 2007.
28.
go back to reference Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis. 1994;18(1):S79–83.CrossRef Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis. 1994;18(1):S79–83.CrossRef
29.
go back to reference Hauser W, Almouhtasseb R. Validierung der deutschen version der fatigue impact scale FIS-D. Z Für Gastroenterol. 2003;41(10):973–82.CrossRef Hauser W, Almouhtasseb R. Validierung der deutschen version der fatigue impact scale FIS-D. Z Für Gastroenterol. 2003;41(10):973–82.CrossRef
30.
go back to reference Interian A, Allen LA, Gara MA, Escobar JI, Díaz-Martínez AM. Somatic complaints in primary care: further examining the validity of the patient health questionnaire (PHQ-15). Psychosomatics. 2006;47(5):392–8.CrossRef Interian A, Allen LA, Gara MA, Escobar JI, Díaz-Martínez AM. Somatic complaints in primary care: further examining the validity of the patient health questionnaire (PHQ-15). Psychosomatics. 2006;47(5):392–8.CrossRef
31.
go back to reference Kroenke K, Spitzer RL, Williams JBW. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med. 2002;64(2):258–66.CrossRef Kroenke K, Spitzer RL, Williams JBW. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med. 2002;64(2):258–66.CrossRef
32.
go back to reference Buonsenso D, Parri N, De Rose C, Valentini P. Toward a clinically based classification of disease severity for paediatric COVID-19. Lancet Infect Dis. 2021;21(1):22.CrossRef Buonsenso D, Parri N, De Rose C, Valentini P. Toward a clinically based classification of disease severity for paediatric COVID-19. Lancet Infect Dis. 2021;21(1):22.CrossRef
36.
go back to reference Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626–31.CrossRef Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626–31.CrossRef
37.
go back to reference Torjesen I. COVID-19: Middle-aged women face greater risk of debilitating long-term symptoms. BMJ. 2021;25: n829.CrossRef Torjesen I. COVID-19: Middle-aged women face greater risk of debilitating long-term symptoms. BMJ. 2021;25: n829.CrossRef
38.
go back to reference Malkova A, Kudryavtsev I, Starshinova A, Kudlay D, Zinchenko Y, Glushkova A, et al. Post COVID-19 syndrome in patients with asymptomatic/mild form. Pathogens. 2021;10(11):1408.CrossRef Malkova A, Kudryavtsev I, Starshinova A, Kudlay D, Zinchenko Y, Glushkova A, et al. Post COVID-19 syndrome in patients with asymptomatic/mild form. Pathogens. 2021;10(11):1408.CrossRef
40.
go back to reference Doykov I, Hällqvist J, Gilmour KC, Grandjean L, Mills K, Heywood WE. ‘The long tail of Covid-19’—The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients. F1000Research. 2021;9:1349.CrossRef Doykov I, Hällqvist J, Gilmour KC, Grandjean L, Mills K, Heywood WE. ‘The long tail of Covid-19’—The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients. F1000Research. 2021;9:1349.CrossRef
41.
go back to reference van der Heide I, Wang J, Droomers M, Spreeuwenberg P, Rademakers J, Uiters E. The relationship between health, education, and health literacy: results from the Dutch adult literacy and life skills survey. J Health Commun. 2013;18(sup1):172–84.CrossRef van der Heide I, Wang J, Droomers M, Spreeuwenberg P, Rademakers J, Uiters E. The relationship between health, education, and health literacy: results from the Dutch adult literacy and life skills survey. J Health Commun. 2013;18(sup1):172–84.CrossRef
42.
go back to reference Schou TM, Joca S, Wegener G, Bay-Richter C. Psychiatric and neuropsychiatric sequelae of COVID-19—a systematic review. Brain Behav Immun. 2021;97:328–48.CrossRef Schou TM, Joca S, Wegener G, Bay-Richter C. Psychiatric and neuropsychiatric sequelae of COVID-19—a systematic review. Brain Behav Immun. 2021;97:328–48.CrossRef
43.
go back to reference Hayes LD, Ingram J, Sculthorpe NF. More than 100 persistent symptoms of SARS-CoV-2 (Long COVID): a scoping review. Front Med. 2021;1(8): 750378.CrossRef Hayes LD, Ingram J, Sculthorpe NF. More than 100 persistent symptoms of SARS-CoV-2 (Long COVID): a scoping review. Front Med. 2021;1(8): 750378.CrossRef
44.
go back to reference Kroencke DC, Lynch SG, Denney DR. Fatigue in multiple sclerosis: relationship to depression, disability, and disease pattern. Mult Scler J. 2000;6(2):131–6.CrossRef Kroencke DC, Lynch SG, Denney DR. Fatigue in multiple sclerosis: relationship to depression, disability, and disease pattern. Mult Scler J. 2000;6(2):131–6.CrossRef
45.
go back to reference Chiffi G, Grandgirard D, Sendi P, Dietmann A, Bassetti CLA, Leib SL. Sleep-wake and circadian disorders after tick-borne encephalitis. Microorganisms. 2022;10(2):304.CrossRef Chiffi G, Grandgirard D, Sendi P, Dietmann A, Bassetti CLA, Leib SL. Sleep-wake and circadian disorders after tick-borne encephalitis. Microorganisms. 2022;10(2):304.CrossRef
46.
go back to reference Pedersen M, Asprusten TT, Godang K, Leegaard TM, Osnes LT, Skovlund E, et al. Fatigue in Epstein–Barr virus infected adolescents and healthy controls: a prospective multifactorial association study. J Psychosom Res. 2019;121:46–59.CrossRef Pedersen M, Asprusten TT, Godang K, Leegaard TM, Osnes LT, Skovlund E, et al. Fatigue in Epstein–Barr virus infected adolescents and healthy controls: a prospective multifactorial association study. J Psychosom Res. 2019;121:46–59.CrossRef
47.
go back to reference Fan JL, Kayser B. Fatigue and exhaustion in hypoxia: the role of cerebral oxygenation. High Alt Med Biol. 2016;17(2):72–84.CrossRef Fan JL, Kayser B. Fatigue and exhaustion in hypoxia: the role of cerebral oxygenation. High Alt Med Biol. 2016;17(2):72–84.CrossRef
48.
go back to reference Heming M, Li X, Räuber S, Mausberg AK, Börsch AL, Hartlehnert M, et al. Neurological manifestations of COVID-19 feature T cell exhaustion and dedifferentiated monocytes in cerebrospinal fluid. Immunity. 2021;54(1):164-175.e6.CrossRef Heming M, Li X, Räuber S, Mausberg AK, Börsch AL, Hartlehnert M, et al. Neurological manifestations of COVID-19 feature T cell exhaustion and dedifferentiated monocytes in cerebrospinal fluid. Immunity. 2021;54(1):164-175.e6.CrossRef
49.
go back to reference Jarius S, Pache F, Körtvelyessy P, Jelčić I, Stettner M, Franciotta D, et al. Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients. J Neuroinflammation. 2022;19(1):19.CrossRef Jarius S, Pache F, Körtvelyessy P, Jelčić I, Stettner M, Franciotta D, et al. Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients. J Neuroinflammation. 2022;19(1):19.CrossRef
50.
go back to reference Share JB. Review of drug treatment for Down’s syndrome persons. Am J Ment Defic. 1976;80(4):388–93. Share JB. Review of drug treatment for Down’s syndrome persons. Am J Ment Defic. 1976;80(4):388–93.
51.
go back to reference Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015;372(19):1832–43.CrossRef Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015;372(19):1832–43.CrossRef
52.
go back to reference St Clair Gibson A, Baden DA, Lambert MI, Lambert EV, Harley YXR, Hampson D, et al. The conscious perception of the sensation of Fatigue. Sports Med. 2003;33(3):167–76.CrossRef St Clair Gibson A, Baden DA, Lambert MI, Lambert EV, Harley YXR, Hampson D, et al. The conscious perception of the sensation of Fatigue. Sports Med. 2003;33(3):167–76.CrossRef
53.
go back to reference Zadra JR, Clore GL. Emotion and perception: the role of affective information: emotion and perception. Wiley Interdiscip Rev Cogn Sci. 2011;2(6):676–85.CrossRef Zadra JR, Clore GL. Emotion and perception: the role of affective information: emotion and perception. Wiley Interdiscip Rev Cogn Sci. 2011;2(6):676–85.CrossRef
54.
go back to reference Corfield EC, Martin NG, Nyholt DR. Co-occurrence and symptomatology of fatigue and depression. Compr Psychiatry. 2016;71:1–10.CrossRef Corfield EC, Martin NG, Nyholt DR. Co-occurrence and symptomatology of fatigue and depression. Compr Psychiatry. 2016;71:1–10.CrossRef
55.
go back to reference Frontera JA, Boutajangout A, Masurkar AV, Betensky RA, Ge Y, Vedvyas A, et al. Comparison of serum neurodegenerative biomarkers among hospitalized COVID-19 patients versus non-COVID subjects with normal cognition, mild cognitive impairment, or Alzheimer’s dementia. Alzheimers Dement. 2022;18(5):899–910.CrossRef Frontera JA, Boutajangout A, Masurkar AV, Betensky RA, Ge Y, Vedvyas A, et al. Comparison of serum neurodegenerative biomarkers among hospitalized COVID-19 patients versus non-COVID subjects with normal cognition, mild cognitive impairment, or Alzheimer’s dementia. Alzheimers Dement. 2022;18(5):899–910.CrossRef
56.
go back to reference Reiken S, Sittenfeld L, Dridi H, Liu Y, Liu X, Marks AR. Alzheimer’s-like signaling in brains of COVID-19 patients. Alzheimers Dement. 2022;18(5):955–65.CrossRef Reiken S, Sittenfeld L, Dridi H, Liu Y, Liu X, Marks AR. Alzheimer’s-like signaling in brains of COVID-19 patients. Alzheimers Dement. 2022;18(5):955–65.CrossRef
57.
go back to reference Godard J, Grondin S, Baruch P, Lafleur MF. Psychosocial and neurocognitive profiles in depressed patients with major depressive disorder and bipolar disorder. Psychiatry Res. 2011;190(2–3):244–52.CrossRef Godard J, Grondin S, Baruch P, Lafleur MF. Psychosocial and neurocognitive profiles in depressed patients with major depressive disorder and bipolar disorder. Psychiatry Res. 2011;190(2–3):244–52.CrossRef
58.
go back to reference McClintock SM, Husain MM, Greer TL, Cullum CM. Association between depression severity and neurocognitive function in major depressive disorder: a review and synthesis. Neuropsychology. 2010;24(1):9–34.CrossRef McClintock SM, Husain MM, Greer TL, Cullum CM. Association between depression severity and neurocognitive function in major depressive disorder: a review and synthesis. Neuropsychology. 2010;24(1):9–34.CrossRef
59.
go back to reference Schwert C, Stohrer M, Aschenbrenner S, Weisbrod M, Schröder A. Neurocognitive profile of outpatients with unipolar depressive disorders. J Clin Exp Neuropsychol. 2019;41(9):913–24.CrossRef Schwert C, Stohrer M, Aschenbrenner S, Weisbrod M, Schröder A. Neurocognitive profile of outpatients with unipolar depressive disorders. J Clin Exp Neuropsychol. 2019;41(9):913–24.CrossRef
60.
go back to reference Mohn C, Rund BR. Neurocognitive profile in major depressive disorders: relationship to symptom level and subjective memory complaints. BMC Psychiatry. 2016;16(1):108.CrossRef Mohn C, Rund BR. Neurocognitive profile in major depressive disorders: relationship to symptom level and subjective memory complaints. BMC Psychiatry. 2016;16(1):108.CrossRef
61.
go back to reference Fleischer M, Köhrmann M, Dolff S, Szepanowski F, Schmidt K, Herbstreit F, et al. Observational cohort study of neurological involvement among patients with SARS-CoV-2 infection. Ther Adv Neurol Disord. 2021;14:175628642199370.CrossRef Fleischer M, Köhrmann M, Dolff S, Szepanowski F, Schmidt K, Herbstreit F, et al. Observational cohort study of neurological involvement among patients with SARS-CoV-2 infection. Ther Adv Neurol Disord. 2021;14:175628642199370.CrossRef
62.
go back to reference Sykes DL, Holdsworth L, Jawad N, Gunasekera P, Morice AH, Crooks MG. Post-COVID-19 symptom burden: What is long-COVID and how should we manage it? Lung. 2021;199(2):113–9.CrossRef Sykes DL, Holdsworth L, Jawad N, Gunasekera P, Morice AH, Crooks MG. Post-COVID-19 symptom burden: What is long-COVID and how should we manage it? Lung. 2021;199(2):113–9.CrossRef
63.
go back to reference van Helvoort MA, Pop-Purceleanu M, Tendolkar I, Everaerd DS. Neuropsychiatric recovery after COVID-19—an observational cohort-study. Tijdschr Voor Psychiatr. 2021;63(7):514–21. van Helvoort MA, Pop-Purceleanu M, Tendolkar I, Everaerd DS. Neuropsychiatric recovery after COVID-19—an observational cohort-study. Tijdschr Voor Psychiatr. 2021;63(7):514–21.
64.
65.
go back to reference Fink G. Die interdisziplinäre S 3-Leitlinie Demenzen: Fortschritte der Neurologie Psychiatrie. Fortschritte Neurol Psychiatr. 2010;78(09):503–4.CrossRef Fink G. Die interdisziplinäre S 3-Leitlinie Demenzen: Fortschritte der Neurologie Psychiatrie. Fortschritte Neurol Psychiatr. 2010;78(09):503–4.CrossRef
67.
go back to reference Román GC, Gracia F, Torres A, Palacios A, Gracia K, Harris D. Acute Transverse Myelitis (ATM): clinical review of 43 patients with COVID-19-associated ATM and 3 post-vaccination ATM serious adverse events with the ChAdOx1 nCoV-19 Vaccine (AZD1222). Front Immunol. 2021;26(12): 653786.CrossRef Román GC, Gracia F, Torres A, Palacios A, Gracia K, Harris D. Acute Transverse Myelitis (ATM): clinical review of 43 patients with COVID-19-associated ATM and 3 post-vaccination ATM serious adverse events with the ChAdOx1 nCoV-19 Vaccine (AZD1222). Front Immunol. 2021;26(12): 653786.CrossRef
68.
go back to reference Sedaghat Z, Karimi N. Guillain Barre syndrome associated with COVID-19 infection: a case report. J Clin Neurosci. 2020;76:233–5.CrossRef Sedaghat Z, Karimi N. Guillain Barre syndrome associated with COVID-19 infection: a case report. J Clin Neurosci. 2020;76:233–5.CrossRef
69.
go back to reference Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG, et al. Guillain-Barré syndrome associated with SARS-CoV-2. N Engl J Med. 2020;382(26):2574–6.CrossRef Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG, et al. Guillain-Barré syndrome associated with SARS-CoV-2. N Engl J Med. 2020;382(26):2574–6.CrossRef
70.
go back to reference Chan JL, Murphy KA, Sarna JR. Myoclonus and cerebellar ataxia associated with COVID-19: a case report and systematic review. J Neurol. 2021;268(10):3517–48.CrossRef Chan JL, Murphy KA, Sarna JR. Myoclonus and cerebellar ataxia associated with COVID-19: a case report and systematic review. J Neurol. 2021;268(10):3517–48.CrossRef
71.
go back to reference Matta J, Wiernik E, Robineau O, Carrat F, Touvier M, Severi G, et al. Association of self-reported COVID-19 infection and SARS-CoV-2 serology test results with persistent physical symptoms among French adults during the COVID-19 pandemic. JAMA Intern Med. 2022;182(1):19.CrossRef Matta J, Wiernik E, Robineau O, Carrat F, Touvier M, Severi G, et al. Association of self-reported COVID-19 infection and SARS-CoV-2 serology test results with persistent physical symptoms among French adults during the COVID-19 pandemic. JAMA Intern Med. 2022;182(1):19.CrossRef
72.
go back to reference Skoda EM, Bäuerle A, Schweda A, Dörrie N, Musche V, Hetkamp M, et al. Severely increased generalized anxiety, but not COVID-19-related fear in individuals with mental illnesses: a population-based cross-sectional study in Germany. Int J Soc Psychiatry. 2021;67(5):550–8.CrossRef Skoda EM, Bäuerle A, Schweda A, Dörrie N, Musche V, Hetkamp M, et al. Severely increased generalized anxiety, but not COVID-19-related fear in individuals with mental illnesses: a population-based cross-sectional study in Germany. Int J Soc Psychiatry. 2021;67(5):550–8.CrossRef
73.
go back to reference Thye AYK, Law JWF, Tan LTH, Pusparajah P, Ser HL, Thurairajasingam S, et al. Psychological symptoms in COVID-19 patients: insights into pathophysiology and risk factors of long COVID-19. Biology. 2022;11(1):61.CrossRef Thye AYK, Law JWF, Tan LTH, Pusparajah P, Ser HL, Thurairajasingam S, et al. Psychological symptoms in COVID-19 patients: insights into pathophysiology and risk factors of long COVID-19. Biology. 2022;11(1):61.CrossRef
74.
go back to reference Mazza MG, Zanardi R, Palladini M, Rovere-Querini P, Benedetti F. Rapid response to selective serotonin reuptake inhibitors in post-COVID depression. Eur Neuropsychopharmacol. 2022;54:1–6.CrossRef Mazza MG, Zanardi R, Palladini M, Rovere-Querini P, Benedetti F. Rapid response to selective serotonin reuptake inhibitors in post-COVID depression. Eur Neuropsychopharmacol. 2022;54:1–6.CrossRef
75.
go back to reference Hulme K, Hudson JL, Rojczyk P, Little P, Moss-Morris R. Biopsychosocial risk factors of persistent fatigue after acute infection: a systematic review to inform interventions. J Psychosom Res. 2017;99:120–9.CrossRef Hulme K, Hudson JL, Rojczyk P, Little P, Moss-Morris R. Biopsychosocial risk factors of persistent fatigue after acute infection: a systematic review to inform interventions. J Psychosom Res. 2017;99:120–9.CrossRef
76.
go back to reference Lim EJ, Son CG. Review of case definitions for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). J Transl Med. 2020;18(1):289.CrossRef Lim EJ, Son CG. Review of case definitions for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). J Transl Med. 2020;18(1):289.CrossRef
77.
go back to reference Premraj L, Kannapadi NV, Briggs J, Seal SM, Battaglini D, Fanning J, et al. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis. J Neurol Sci. 2022;434: 120162.CrossRef Premraj L, Kannapadi NV, Briggs J, Seal SM, Battaglini D, Fanning J, et al. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis. J Neurol Sci. 2022;434: 120162.CrossRef
78.
go back to reference Kocalevent RD, Hinz A, Brähler E. Standardization of a screening instrument (PHQ-15) for somatization syndromes in the general population. BMC Psychiatry. 2013;20(13):91.CrossRef Kocalevent RD, Hinz A, Brähler E. Standardization of a screening instrument (PHQ-15) for somatization syndromes in the general population. BMC Psychiatry. 2013;20(13):91.CrossRef
79.
go back to reference van Ravesteijn H, Wittkampf K, Lucassen P, van de Lisdonk E, van den Hoogen H, van Weert H, et al. Detecting somatoform disorders in primary care with the PHQ-15. Ann Fam Med. 2009;7(3):232–8.CrossRef van Ravesteijn H, Wittkampf K, Lucassen P, van de Lisdonk E, van den Hoogen H, van Weert H, et al. Detecting somatoform disorders in primary care with the PHQ-15. Ann Fam Med. 2009;7(3):232–8.CrossRef
Metadata
Title
Post-COVID-19 Syndrome is Rarely Associated with Damage of the Nervous System: Findings from a Prospective Observational Cohort Study in 171 Patients
Authors
Michael Fleischer
Fabian Szepanowski
Muriel Tovar
Klaas Herchert
Hannah Dinse
Adam Schweda
Anne K. Mausberg
Dagny Holle-Lee
Martin Köhrmann
Julia Stögbauer
Daniel Jokisch
Martha Jokisch
Cornelius Deuschl
Eva-Maria Skoda
Martin Teufel
Mark Stettner
Christoph Kleinschnitz
Publication date
26-08-2022
Publisher
Springer Healthcare
Published in
Neurology and Therapy / Issue 4/2022
Print ISSN: 2193-8253
Electronic ISSN: 2193-6536
DOI
https://doi.org/10.1007/s40120-022-00395-z

Other articles of this Issue 4/2022

Neurology and Therapy 4/2022 Go to the issue